Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Dexcom Announces Upcoming Virtual Conference Presentations
08:45am, Thursday, 02'nd Sep 2021
SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Upcoming Virtual Conference Presentations
Moderna And DexCom Lead The Nasdaq-100
04:21pm, Wednesday, 01'st Sep 2021
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to $380.58
DexCom And O'Reilly Auto Parts Lead The QQQ Monday
04:07pm, Monday, 16'th Aug 2021
U.S. indices bounced off Monday morning's lows as investors weigh weak China retail and production data. Uncertainty around the COVID-19 Delta variant is also weighing on the market.
3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain
10:41pm, Saturday, 31'st Jul 2021
Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.
These 2 Winning Stocks Came Out of Nowhere Friday
05:45pm, Friday, 30'th Jul 2021
Many investors probably haven't even have heard of these big winners.
Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price
01:23pm, Friday, 30'th Jul 2021
Continuous glucose monitor developer Dexcom Inc (NASDAQ: DXCM) shares ticked up as second-quarter results easily topped the consensus forecast; adjusted EPS of 0.76 beat the consensus of $0.45. Sa
Why Shares of Dexcom Are Gaining This Morning
11:39am, Friday, 30'th Jul 2021
Wall Street is thrilled with acceleration out of the pandemic and a new product on the horizon.
DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates
10:39am, Friday, 30'th Jul 2021
DexCom's (DXCM) second-quarter results benefit from domestic and international revenue growth and solid new customer additions.
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q2 2021 Results - Earnings Call Transcript
10:41pm, Thursday, 29'th Jul 2021
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q2 2021 Results - Earnings Call Transcript
Dexcom CEO on building a body of evidence to support pipeline of technology
07:25pm, Thursday, 29'th Jul 2021
Dexcom CEO Kevin Sayer discussed advancements the company has made to help patients manage and treat diabetes.
DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates
07:00pm, Thursday, 29'th Jul 2021
DexCom (DXCM) delivered earnings and revenue surprises of 76.74% and 8.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: DexCom Q2 Earnings
04:50pm, Thursday, 29'th Jul 2021
Shares of DexCom (NASDAQ:DXCM) rose 3.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 3.80% year over year to $0.76, which beat the est
New Strong Sell Stocks for July 28th
10:39am, Wednesday, 28'th Jul 2021
AEVA, BKD, CSGS, DXCM and EIG have been added to the Zacks Rank #5 (Strong Sell) List on July 28, 2021.
DexCom (DXCM) to Report Q2 Earnings: What's in the Cards?
09:13am, Friday, 23'rd Jul 2021
DexCom's (DXCM) second-quarter results are likely to reflect rising global awareness of its real-time CGM.
Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod
12:13pm, Monday, 19'th Jul 2021
Recent regulatory clearance of Dexcom's (DXCM) real-time APIs is expected to aid diabetics as well as their care providers in accessing GCM data.
